Literature DB >> 25367460

Hepatocyte growth factor deficiency in COPD: a mechanism of emphysema and small airway fibrosis?

Peter J Barnes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25367460     DOI： 10.1378/chest.14-1194

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

Review 1.  Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs.

Authors:  Gabriele Grunig; Aram Baghdassarian; Sung-Hyun Park; Serhiy Pylawka; Bertram Bleck; Joan Reibman; Erika Berman-Rosenzweig; Nedim Durmus
Journal:  Biomark Insights       Date:  2016-02-16

2.  β2-microglobulin as a biomarker of pulmonary fibrosis development in COPD patients.

Authors:  Zhenchao Wu; Mengdie Yan; Min Zhang; Nan Wu; Guoyuan Ma; Bingbing Wang; Youbo Fan; Xintong Du; Can Ding; Yi Liu
Journal:  Aging (Albany NY)       Date:  2020-12-21       Impact factor: 5.682

Review 3.  Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.

Authors:  Alexander Markov; Lakshmi Thangavelu; Surendar Aravindhan; Angelina Olegovna Zekiy; Mostafa Jarahian; Max Stanley Chartrand; Yashwant Pathak; Faroogh Marofi; Somayeh Shamlou; Ali Hassanzadeh
Journal:  Stem Cell Res Ther       Date:  2021-03-18       Impact factor: 6.832

4.  Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema.

Authors:  Shravani Pasupneti; Wen Tian; Allen B Tu; Petra Dahms; Eric Granucci; Aneta Gandjeva; Menglan Xiang; Eugene C Butcher; Gregg L Semenza; Rubin M Tuder; Xinguo Jiang; Mark R Nicolls
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 30.528

5.  Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease.

Authors:  Jun Ikari; Amy J Nelson; Jannah Obaid; Alvaro Giron-Martinez; Kumiko Ikari; Fumihiko Makino; Shunichiro Iwasawa; Yoko Gunji; Maha Farid; Xingqi Wang; Hesham Basma; Dawn Demeo; Carol Feghali-Bostwick; Olaf Holz; Klaus Rabe; Xiangde Liu; Stephen I Rennard
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

6.  A drug screen with approved compounds identifies amlexanox as a novel Wnt/β-catenin activator inducing lung epithelial organoid formation.

Authors:  Rita Costa; Darcy E Wagner; Ali Doryab; Martina M De Santis; Kenji Schorpp; Ina Rothenaigner; Mareike Lehmann; Hoeke A Baarsma; Xueping Liu; Otmar Schmid; Monica Campillos; Ali Önder Yildirim; Kamyar Hadian; Melanie Königshoff
Journal:  Br J Pharmacol       Date:  2021-07-31       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.